More PRNewswire
View Older Stories View Newer Stories-
Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 an
-
OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
-
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
-
VolitionRx Announces Pricing of $4.6 Million Public Offering
-
Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
-
Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
-
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
-
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
-
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
-
Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
-
Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
-
MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale
-
Soules Kitchen Declares June 7th (6/7) the Official Day of Delightful Dinners
-
Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026
-
Bitty & Beau's Coffee Launches New Mini Cruiser Franchise Model
-
Vision Insurance After Retirement (2026): VSP Vision Care Named Leading Option for Retiree Eye Coverage by Expert Consumers
-
Bybit Launches IPO Express, Becoming One of First Centralized Crypto Exchanges to Offer Tokenized IPO Access, Starting With SpaceX
-
Looney Tunes™ Land Now Open at Six Flags Magic Mountain
-
"Tides & Voices" Salon: Consolidating the Foundation for Peace and Development in the South China Sea Through Dialogue and Cooperation
-
A New Era Begins: Cal Poly Unveils the John Madden Football Center
-
The American Diabetes Association Announces Winners of the Innovation Challenge
-
Texas Southern University Expands Elite Flight Training Fleet with New Twin-Engine Aircraft
-
Duke Energy offers tips to save energy and money as temperatures rise in the Carolinas
-
AMERICANS SWEEP ST. PETE AS RED BULL CLIFF DIVING WORLD SERIES MAKES HISTORIC FLORIDA DEBUT
-
From Bystanders to Heart Savers: MedStar Health CPR Training Event Puts Power to Save Lives in Community's Hands
-
Philippine Airlines to Join oneworld Alliance
-
Ramtech VP of Business Development Kelly Williams to Speak on Modular Construction Benefits in Panel Discussion at 2026 InterFace Houston Multifamily Conference
-
University of Phoenix researchers publish study examining doctoral students' attitudes toward AI chatbots and ChatGPT use in higher education
-
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
-
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and i
-
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
-
Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions
-
/C O R R E C T I O N -- U.S. Postal Service/
-
TEAMEX Delivers First EV-Drill LANCE in the United States to Pennsylvania Fire Department
-
In HelloNation, Periodontics Expert Dr. Scott Kissel of Manhattan, NY, Details Why Microsurgical Techniques Matter in Periodontal Care
-
Clinical Amino Acid Profiles Anchor PureHealth Research's New Natural Peptides Supplements
-
PureHealth Research Highlights Growing Consumer Interest in Lymphatic Wellness and Botanical Support
-
People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched t
-
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
-
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
-
Leading Vision Insurance for Glasses (2026): VSP Individual Vision Plans Named Top Plan for Frames and Lens Coverage by Better Business Advice
-
Shuja Rabbani Positions Human Resources as a Strategic Force for the GCC's Next Era of Business Transformation
-
CST Tires Showcases Lightweight Innovation at 2026 China International Bicycle Expo
-
Think Together Awards 2026 Beyond Think Together Scholarships to Ten High School Seniors Across the State
-
46 Greenberg Traurig Attorneys Recognized in 2026 IAM Patent 1000
-
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
-
Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate
-
Novo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026
-
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
-
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
